Loading
Gestational Diabetes Research and Management · Journal article
International Journal of Medical Sciences · September 3, 2026
A consensus or society position rather than new primary data.
This is a narrative review of insulin resistance in pregnancy (IRiP) that synthesizes current understanding of its pathogenesis, risk factors, assessment methods, and intervention strategies. The review positions moderate physiological IRiP as protective for fetal development, but notes that excessive IRiP increases risks for both maternal complications and long-term offspring morbidity. It does not report original empirical findings or quantify the strength of evidence for specific interventions.
Narrative review. Pregnant women; discussion includes effects on offspring short- and long-term health..
Physiological moderate increase in IRiP is protective for fetal development Excessive IRiP enhancement increases risk of gestational diabetes and adverse pregnancy outcomes Degree of IRiP affects pregnancy outcomes regardless of gestational diabetes presence
Excessive IRiP enhancement increases risk of gestational diabetes and adverse pregnancy outcomes Adverse effects on offspring include future obesity and metabolic diseases
Clinicians should recognize that IRiP assessment and management require individualized approaches, as moderate physiological IRiP supports fetal development but excessive levels confer maternal and fetal/neonatal risks. This review provides a framework for understanding when intervention may be warranted, though specific efficacy estimates for individual interventions are not quantified in the abstract.
A narrative review synthesizing current knowledge on insulin resistance in pregnancy, its pathogenesis, assessment, and management strategies; provides expert synthesis rather than original evidence of efficacy.
As stated by the source record.
Clinicians should recognize that IRiP assessment and management require individualized approaches, as moderate physiological IRiP supports fetal development but excessive levels confer maternal and fetal/neonatal risks. This review provides a framework for understanding when intervention may be warranted, though specific efficacy estimates for individual interventions are not quantified in the abstract.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Evidence suggests that the degree of insulin resistance in pregnancy (IRiP) seems to affect pregnancy outcomes regardless of the presence of gestational diabetes.A physiological moderate increase in IRiP is a protective factor for fetal development, but excessive enhancement can lead to maternal metabolic disorders and placental dysfunction, increasing the risk of gestational diabetes and adverse pregnancy outcomes, as well as having adverse effects on the long-term health of the offspring.This review briefly explores the key factors influencing IRiP, including pregnancy-specific and non-pregnancy-specific factors.It also discusses the assessment methods for insulin resistance that can be implemented during pregnancy and the increased probabilities of adverse effects on both the mother and the offspring, such as preeclampsia or eclampsia, neonatal hypoglycemia, and the risk of obesity and metabolic diseases in the offspring in the future.Finally, the intervention strategies were briefly described, such as in terms of diet, exercise, and medication, etc.This provides a basis and insights for the management and research of IRiP.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.